Japanese Cell Phone Makers Tap Android


Japanese cell phone makers are attempting to enter the growing worldwide mobile device market by adopting Google’s (GOOG) Android according to the New York Times.

Japanese mobile phones are already more advanced than many on the market elsewhere, with some that double as credit cards, can display digital TV broadcasts and are equipped with solar cells. But the Times reported that Japanese cell phones haven’t taken off elsewhere in a market dominated by Apple (AAPL), Research in Motion (RIMM) and Samsung.

To better compete internationally, Japanese cell phone makers like Sharp, Sony Ericsson, NEC and Kyocera will all adopt Google’s Android mobile operating system. According to the Times, Sharp has already introduced a line of tablet computers running Android to the U.S. market to compete with the iPad.

Apple’s iPhone initially overshadowed devices running the Android operating system, but the number of Android numbers is now rising rapidly, the Times reported. Worldwide sales of Android phones hit 67.2 million units in 2010, way ahead of the 46 million units for the iPhone.

GOOG and AAPL are both Cabot Top Ten Weekly stocks.

Stock Picks


This stock could rise 50% before becoming fairly valued.

This hot technology company is growing like a weed, thanks to products that speed up cloud communications.

This stock is somewhat well known, but far from well loved.

Cabot Wealth Advisory

How to Find Great Growth Stocks in a Scary Market

By Paul Goodwin on October 21, 2016

Even in today’s scary market, there are great growth stocks out there. Here’s how to find them—and how to avoid the kind of losses that can haunt your portfolio.Read More >

Buy This Small-Cap Tech Stock as the Nasdaq Thrives

By Tyler Laundon on October 20, 2016

Technology stocks are thriving, as the Nasdaq has been outpacing the S&P 500 and the Dow for months. And one small-cap tech stock in particular is outperforming the industry’s big boys. Read More >

Is Allergan (AGN) Still an Undervalued Stock?

By Crista Huff on October 18, 2016

Five months ago, Allergan (AGN) was an undervalued stock with tons of growth potential. It's up 21% since then, but still has plenty of upside. Here's why.Read More >